Top 10 CBD Oil Stocks

CBDISTILLERY

Buy CBD Oil Online

In this article, we will take a look at the 10 best CBD stocks to invest in. You can skip our comprehensive analysis of the cannabidiol market, and industry outlook for 2021 and go directly to the 5 Best CBD Stocks to Invest In. With the increase of sales, legalization, and medical and recreational benefits, […] The rampant growth of the cannabis industry has sparked investor interest in CBD oil stocks. Consider investing in these stocks to grow your portfolio organically. Find out which companies are dominating the industry and how to invest in them. Here are the top 10 CBD oil stocks to buy right now.

10 Best CBD Stocks to Invest In

In this article, we will take a look at the 10 best CBD stocks to invest in. You can skip our comprehensive analysis of the cannabidiol market, and industry outlook for 2021 and go directly to the 5 Best CBD Stocks to Invest In .

With the increase of sales, legalization, and medical and recreational benefits, the cannabis industry has proven its resilience and managed to grow in the face of the COVID-19 pandemic. As a result, there is a growing market for cannabidiol compounds. Cannabidiol, or CBD in short, is a constituent of the cannabis plant developed for medical use as it is not psychoactive, meaning it doesn’t get people high. In 2020, the CBD market reached approximately $14.9 billion in sales in the US.

On July 14, Senate Majority Leader Chuck Schumer, Senate Finance Committee Chairman Ron Wyden, and Sen. Cory Booker advocated eliminating cannabis from the Controlled Substances Act, causing US and Canadian cannabis stocks to rise. If passed, the bill would make it easier for private cannabis companies to go public in the United States, either by giving banks more leniency or ending the prohibition of marijuana. Meanwhile, President Joe Biden said that he backed decriminalizing marijuana but that more research on its long-term effects is needed before it could be legalized.

Among the American cannabis companies that soared on the announcement day were Cresco Labs Inc. (OTC: CRLBF) and Curaleaf Holdings, Inc. (OTC: CURLF), which jumped 3.9% and 2.2%, respectively. US-based medical marijuana companies Cresco Labs Inc. (OTC: CRLBF) and Curaleaf Holdings, Inc. (OTC: CURLF) are also among the existing marijuana dispensaries that have been granted a license in New York, where licensed marijuana companies are permitted to expand their marijuana businesses to four additional dispensaries on top of the existing four, with three of the eight being approved for recreational sales. On July 7, Jefferies analyst Owen Bennett gave a bullish rating on Curaleaf Holdings, Inc. (OTC: CURLF) where he initiated a Buy rating for the stock and set a price target of C$32 per share.

New York is now among the 18 states in the US that legalized recreational marijuana after Governor Andrew Cuomo signed the bill on March 31. According to Viridian Capital Advisors, New York be the most significant cannabis market on the East Coast, with sales expected to reach $1.9 billion by 2025.

Should You Invest in CBD Stocks?

According to a report from the BDSA, the cannabis sector had a breakout year in 2020, with global marijuana sales hitting approximately $21.3 billion, up 45% from $14.4 billion in 2019. In the US market, cannabis sales climbed 46% year over year to $17.5 billion in 2020. The sector shows no sign of stopping its growth as global cannabis sales are projected to grow at a compound annual rate of 17 percent to $55.9 billion by 2026, according to BDSA.

With this positive outlook, investors are optimistic about the cannabis industry. Analysts are bullish on CBD stocks like Jazz Pharmaceuticals plc (NASDAQ: JAZZ) and Tilray, Inc. (NASDAQ: TLRY). After completing its $7.2 billion acquisition of GW Pharmaceuticals, investors and analysts keep an eye on Jazz Pharmaceuticals (NASDAQ: JAZZ). On July 15, JPMorgan analyst Jessica Fye maintained an Overweight rating on Jazz Pharmaceuticals (NASDAQ: JAZZ) with a price target of $200 per share.

On the other hand, RBC Capital analyst Daniel Busby maintained an Outperform rating on Jazz Pharmaceuticals plc (NASDAQ: JAZZ) on July 23, increasing the price target to $216 per share from 190 previously. The analyst stated that the company’s FDA-approved Rylaze for acute lymphoblastic leukemia and lymphoblastic lymphoma treatment is a potential growth driver. Shares of Jazz Pharmaceuticals plc (NASDAQ: JAZZ) increased 6% in the last three months and gained 52% in the previous year.

Canadian medical cannabis and cannabinoid producer Tilray, Inc. (NASDAQ: TLRY) is another notable marijuana stock analysts are bullish about. The stock has gained 94% year to date and 10% in the last five days. In May, Jefferies analyst Owen Bennett upgraded Tilray, Inc. (NASDAQ: TLRY) to a Buy rating and increased the firm’s price target to $23 per share. According to the analyst, following its merger with Ontario-based medical marijuana producer Aphria Inc., the marijuana firm is now among the most prominent leaders in the Canadian industry. It also has potential in the US market. On July 27, Cantor Fitzgerald analyst Pablo Zuanic maintained an Overweight rating on Tilray, Inc. (NASDAQ: TLRY) and a price target of $19 per share.

To pick the best CBD stocks for this article, we took into account fundamentals, analyst ratings, future outlook and hedge fund sentiment for some of the most notable CBD stocks in the world. Why pay attention to hedge fund sentiment? Insider Monkey’s research was able to identify in advance a select group of hedge fund holdings that outperformed the S&P 500 ETFs by more than 124 percentage points since March 2017. Between March 2017 and May 29, 2021, our monthly newsletter’s stock picks returned 206.8%, vs. 91% for the SPY. Our stock picks outperformed the market by more than 115 percentage points ( see the details here ). That’s why we believe hedge fund sentiment is an extremely useful indicator that investors should pay attention to. You can subscribe to our free newsletter on our homepage to receive our stories in your inbox.

Let’s now look at the 10 best CBD stocks to invest in.

10 Best CBD Stocks to Invest In

10. OrganiGram Holdings Inc. (NASDAQ: OGI)

Number of Hedge Fund Holders: N/A

We start our list of the 10 best CBD stocks to invest in cannabis producer OrganiGram Holdings Inc. (NASDAQ: OGI). The Canadian weed company manufactures medical and recreational cannabis and CBD products. OrganiGram Holdings Inc. (NASDAQ: OGI) owns a 14-acre facility where the company grows its cannabis.

OrganiGram Holdings Inc. (NASDAQ: OGI) stock increased 2.38% in the last five days after the cannabis company published solid Q3 results, including a 31% increase in gross revenue and a 13% increase in net revenue year over year. On July 14, CIBC analyst John Zamparo reiterated a Neutral rating on OrganiGram Holdings Inc. (NASDAQ: OGI) and increased the price target to C$4 per share from C$3.75 previously.

The company has a market cap of $771 million. In the third quarter of 2021, OrganiGram Holdings Inc. (NASDAQ: OGI) had an EPS of -$0.01, beating estimates by $0.02. The company’s third-quarter revenue was $16.24 million, beating revenue estimates by $2.89 million. The stock has gained 94% in the last twelve months.

Just like Jazz Pharmaceuticals plc (NASDAQ: JAZZ), Tilray, Inc. (NASDAQ: TLRY), Cresco Labs Inc. (OTC: CRLBF), and Curaleaf Holdings, Inc. (OTC: CURLF), OrganiGram Holdings Inc. (NASDAQ: OGI) is one of the best CBD stocks to invest in according to market analysts.

9. Zynerba Pharmaceuticals, Inc. ( NASDAQ: ZYNE )

Number of Hedge Fund Holders: 6

Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) ranks 9th on the list of 10 best CBD stocks to invest in. The Pennsylvania-based clinical-stage pharmaceutical firm develops transdermal CBD medications for chronic neuropsychiatric disorders.

In May, Cantor Fitzgerald analyst Charles Duncan maintained an Overweight rating on Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) and increased the price target to $8 per share from $6 previously. According to the analyst, Zygel, the company’s transdermal CBD medication is headed to a more recognizable path to being used as a medication for Autism Spectrum Disorder and Fragile X Syndrome.

See also  CBD Oil In Indiana Law

The company has a market cap of $187 million. In the first quarter of 2021, Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) had an EPS of -$0.20, beating estimates by $0.05. At the end of the first quarter, the company had cash of $93.1 million, up from $59.2 million in the fourth quarter of 2020. Shares of Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) increased 37% year to date.

By the end of the first quarter of 2021, 6 hedge funds out of the 866 tracked by Insider Monkey held stakes in Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) worth roughly $3.47 million.

Just like Jazz Pharmaceuticals plc (NASDAQ: JAZZ), Tilray, Inc. (NASDAQ: TLRY), Cresco Labs Inc. (OTC: CRLBF), and Curaleaf Holdings, Inc. (OTC: CURLF), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) is one of the best CBD stocks to invest in according to market analysts.

8. Sundial Growers Inc. ( NASDAQ: SNDL )

Number of Hedge Fund Holders: 7

Sundial Growers Inc. (NASDAQ: SNDL) ranks 8th on the list of 10 best CBD stocks to invest in. The Calgary-based cannabis company commercializes adult-use cannabis products in Canada and makes loans to other marijuana companies. In May, Sundial Growers Inc. (NASDAQ: SNDL)

On July 20, ATB Capital analyst David Kideckel upgraded Sundial Growers Inc. (NASDAQ: SNDL) to a Sector Perform from Underperform and increased the price target to $0.80 per share from $0.50 previously, after the company closed its CA$131 million acquisition of cannabis retailer Inner Spirit Holdings Ltd. Shares of Sundial Growers Inc. (NASDAQ: SNDL) increased 1.14% in the previous five days.

The company has a market cap of $1.51 billion. In the first quarter of 2021, Sundial Growers Inc. (NASDAQ: SNDL) had an EPS of -0.00, beating estimates by $0.01. The company’s gross cannabis revenue was $11.75 million in the first quarter, down 29% year over year. Sundial Growers Inc. (NASDAQ: SNDL) has gained over 72% year to date.

By the end of the first quarter of 2021, 7 hedge funds out of the 866 tracked by Insider Monkey held stakes in Sundial Growers Inc. (NASDAQ: SNDL) worth roughly $18.8 million. This is compared to 2 hedge funds in the previous quarter with stakes worth about $2.72 million.

Just like Jazz Pharmaceuticals plc (NASDAQ: JAZZ), Tilray, Inc. (NASDAQ: TLRY), Cresco Labs Inc. (OTC: CRLBF), and Curaleaf Holdings, Inc. (OTC: CURLF), Sundial Growers Inc. (NASDAQ: SNDL) is one of the best CBD stocks to invest in according to market analysts.

7. Village Farms International, Inc. ( NASDAQ: VFF )

Number of Hedge Fund Holders: 8

Village Farms International, Inc. (NASDAQ: VFF) ranks 7th on the list of 10 best CBD stocks to invest in. The Canadian company grows different plant-based products in its vertically integrated greenhouse facility in Delta, Canada. Village Farms International, Inc. (NASDAQ: VFF) operates cannabis and hemp business through its subsidiary Pure Sunfarms.

On July 21, Stifel analyst Andrew Partheniou maintained a Buy rating on Village Farms International, Inc. (NASDAQ: VFF) and increased the stock’s price target to C$22.50 per share from C$22 previously. The stock has gained 5.04% in the last five days. Earlier this month Pure Sunfarms obtained license approval from Health Canada for its 1.1 million square ft Delta 2 cannabis facility, bringing its total cultivation capacity to 1.65 million square ft. Shares of Village Farms International, Inc. (NASDAQ: VFF) increased 5.04% in the last five days.

The company has a market cap of $779 million. In the first quarter of 2021, Village Farms International, Inc. (NASDAQ: VFF) an EPS of -$0.06, missing estimates by -$0.04. The company’s revenue for the first quarter came in at $52.6 million, beating revenue estimates by $1.13 million. The stock has gained 61% in the past twelve months.

By the end of the first quarter of 2021, 8 hedge funds out of the 866 tracked by Insider Monkey held stakes in Village Farms International, Inc. (NASDAQ: VFF) worth roughly $35.5 million. This is compared to 6 hedge funds in the previous quarter with stakes worth about $29.8 million.

Just like Jazz Pharmaceuticals plc (NASDAQ: JAZZ), Tilray, Inc. (NASDAQ: TLRY), Cresco Labs Inc. (OTC: CRLBF), and Curaleaf Holdings, Inc. (OTC: CURLF), Village Farms International, Inc. (NASDAQ: VFF) is one of the best CBD stocks to invest in according to market analysts.

6. Innovative Industrial Properties, Inc. ( NYSE: IIPR )

Number of Hedge Fund Holders: 13

Innovative Industrial Properties, Inc. (NYSE: IIPR) ranks 6th on the list of 10 best CBD stocks to invest in. The San Diego-based company is a real estate investment trust (REIT) that manages medicinal cannabis facilities in the United States.

On July 2, analyst Andrew Rosivach of Wolfe Research began coverage of Innovative Industrial Properties, Inc. (NYSE: IIPR) with an Outperform rating and $249 per share price target. The stock has gained 9% in the previous month as the company declared a quarterly dividend increase of 6.1% to $1.40 per share, up from $1.32 previously.

The company has a market cap of $5.1 billion. In the second quarter of 2021, Innovative Industrial Properties, Inc. (NYSE: IIPR) had an EPS of $1.05, beating estimates by $0.09. The company’s first-quarter revenue came in at $42.8 million, increasing 103% year over year and beating estimates by $1.22 million. The company acquired four properties in the second quarter in Pennsylvania, Michigan, and Massachusetts. As of July 6, Innovative Industrial Properties, Inc. (NYSE: IIPR) owned and leased 72 medical marijuana facilities across 18 states in the US. Shares of Innovative Industrial Properties, Inc. (NYSE: IIPR) increased 17% in the last three months.

At the end of the first quarter of 2021, 13 hedge funds in the database of Insider Monkey held stakes worth $192 million in Innovative Industrial Properties, Inc. (NYSE: IIPR), down from 23 in the preceding quarter worth $317 million.

Just like Jazz Pharmaceuticals plc (NASDAQ: JAZZ), Tilray, Inc. (NASDAQ: TLRY), Cresco Labs Inc. (OTC: CRLBF), and Curaleaf Holdings, Inc. (OTC: CURLF), Innovative Industrial Properties, Inc. (NYSE: IIPR) is one of the best CBD stocks to invest in according to market analysts.

Click to continue reading and see the 5 Best CBD Stocks to Invest In.

Disclosure: None. 10 Best CBD Stocks to Invest In is originally published on Insider Monkey.

Best CBD Oil Stocks

Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world’s largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company’s Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%). They are considered a leader in the cannabis and tobacco industry.

Day Range 45.04 – 45.86 52 Wk Range 41 – 57.05 Open / Close 45.24 / 45.57 Float / Outstanding – / 1.8B
Vol / Avg. 7.8M / 10.6M Mkt Cap 82.1B P/E 46.07 50d Avg. Price 43.93
Div / Yield 3.76/8.33% Payout Ratio 367.35 Total Float – EPS –

Jazz Pharmaceuticals ( XNAS: JAZZ )

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and indications in neuroscience and hematology-oncology. Jazz’s product portfolio includes its lead drug, Xyrem, for narcolepsy, Sunosi for improving wakefulness in patients with excessive daytime sleepiness, Defitelio for severe veno-occlusive disease after stem cell transplant, Vyxeos for acute myeloid leukemia, and Zepzelca for small cell lung cancer.

See also  Where To Buy CBD Oil On Long Island
Day Range 151.99 – 154.29 52 Wk Range 126.14 – 169.98 Open / Close 152.11 / 152.66 Float / Outstanding – / 62.7M
Vol / Avg. 374.6K / 488.3K Mkt Cap 9.6B P/E – 50d Avg. Price 156.18
Div / Yield – Payout Ratio – Total Float – EPS –

Village Farms Intl ( XNAS: VFF )

As one of the largest and longest-operating greenhouse growers in North America, Village Farms International produces and distributes premium cannabis to national growers in the U.S. and Canada.

The cannabis stock has a market cap of $288 million and trades over 1 million shares per day. It has an EPS of $0.04 and a P/E ratio of 128. Village Farms International generated total revenue of $144 million in 2019, making it one of the best stocks under $10.

Village Farm International recently reported its revenue in Q1 2020 and declared that it has had a profitable business for the 5th consecutive quarter. The cannabis company has also announced that it has expanded its credit facility with its existing lender by $59 million.

Day Range 2.51 – 2.62 52 Wk Range 2.44 – 7.22 Open / Close 2.51 / 2.57 Float / Outstanding – / 88.6M
Vol / Avg. 639.5K / 680.7K Mkt Cap 227.6M P/E – 50d Avg. Price 2.84
Div / Yield – Payout Ratio – Total Float – EPS –

GrowGeneration ( XNAS: GRWG )

GrowGeneration Corp. is a premier supplier of cannabis and cannabis-growing equipment. These products include organic nutrients, drip systems, water pumps, air pumps, LED lights and commercial light systems. It is the largest hydroponic supplier in the U.S., with 31 retail and distribution centers.

The cannabis stock has a market cap of $849 million and has an EPS of $0.02. It has an annual dividend yield of $0.02 per share. GrowGeneration has high liquidity and trades more than 1.7 million shares per day. It generated revenue of $79 million in 2019.

Day Range 4.55 – 4.79 52 Wk Range 3.42 – 14.1 Open / Close 4.58 / 4.72 Float / Outstanding – / 60.8M
Vol / Avg. 730.4K / 1.4M Mkt Cap 286.9M P/E – 50d Avg. Price 4.76
Div / Yield – Payout Ratio – Total Float – EPS –

AbbVie ( XNYS: ABBV )

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The company’s top drug, Humira, represents close to half of the company’s current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women’s health.

Day Range 140.1 – 142.17 52 Wk Range 128.26 – 175.91 Open / Close 140.4 / 141.42 Float / Outstanding – / 1.8B
Vol / Avg. 4.4M / 5.5M Mkt Cap 250B P/E 19.88 50d Avg. Price 144.55
Div / Yield 5.64/4.01% Payout Ratio 76.66 Total Float – EPS –

After the legalization of marijuana in the U.S., many companies are actively engaged in the research, development and distribution of cannabis. Cannabidiol (CBD) is the non-psychoactive substance present within cannabis and its products such as CBD oil has had a major impact on the health and wellness industry.

Take a look at these CBD oil stocks that are generating millions of dollars in revenue this year.

Overview: CBD Oil Stocks

Since ancient times, cannabis has been used as a form of medicine and as a means to induce euphoria. Indian sages have also mentioned the medicinal use of marijuana in Vedic hymns of antiquity.

However, President Richard Nixon banned the cultivation and sale of marijuana in the U.S. as part of his “war on drugs” campaign in 1970. It wasn’t until the Compassionate Use Act of 1996 was passed that California became the first state to legalize marijuana to treat people with severe or chronic diseases. As of 2022, 37 states in the U.S. have legalized the medical use of marijuana and 18 states have legalized the recreational use of marijuana.

According to a recent report by the New Frontier Data, the legal sale of cannabis could reach $30 billion by 2025. Due to such high potential to earn profits, alcohol companies have started to invest big in CBD oil companies.

Constellation Brands Inc. (NYSE: STZ) has invested billions in Canopy Growth Corp. (NYSE: CGC). Molson Coors (NYSE: TAP) invested billions in Hexo (TSX: HEXO). Budweiser (NYSE: BUD) entered a joint venture to develop non-alcoholic CBD drinks with Tilray Inc. (NASDAQ: TLRY).

You can still catch up with the market trend and gain some good earnings by investing in CBD oil stocks today.

Best Online Brokers for CBD Oil Stock

Online brokers let you browse and trade thousands of stocks listed on major stock exchanges. These platforms are bundled with tons of educational resources and tools to let you manage your stock portfolio on the go. Many of these online brokers also allow you to trade stocks commission-free.

Best CBD Stocks to Buy: Top Ten Picks

With the growing popularity of medical marijuana across North America, many investors consider investing in stock-exchange listed companies. Investing in CBD stocks is a good idea if you’re looking for an investment with high course potential. Many different companies produce CBD products, and they all have their strengths and weaknesses. As someone who has done extensive research on the best cbd stocks to invest in, I will list my top 10 favorite companies for 2022 listed on NYSE and Nasdaq.

Keep in mind, CDB stocks are currently not in investors focus, and many of them are at longer-term lows right now. It needs to become an attractive investment field with more media dominance again before investments become worthwhile again.

Transparency: We may get compensated when you click on links in this article.

We’ve added current analyst estimates and company fundamentals to each company in the list using the fundamental analysis platform Stock Rover. You can use the free 14-day Stock Rover trial to check the most recent statistics, peers and stock analysis.

What are CBD Oil Stocks

CBD oil stocks refer to companies that produce and distribute CBD products. Companies like these are usually best suited for long-term investments because they have high potential growth over the next decade or more.

What is CDB Oil

CBD oil is a type of natural herb that has been used for many different purposes, including medical and recreational. CBD oils are typically extracted from hemp plants, making them legal in the United States under federal law.

What Brokers to Use to Buy CDB Oil Stocks

The best brokers to buy CDB oil stocks with are either TD Ameritrade or E*TRADE. They’re both straightforward to use and have many great tools that will make investing easier for beginners.

The Best CDB Stocks to Buy

Table of Contents

1. Jazz Pharmaceuticals (JAZZ)

The Ireland-domiciled biopharma company Jazz Pharmaceuticals focuses on treatments for indications in neuroscience, sleeping disorders and hematology-oncology. Jazz Pharmaceuticals still has a negative EPS of -5.46 with a market cap of $10.5 billion. In December 2021, the stock hit a mid-term low at $117.64 and then started a rally to nearly $170 in April 2022.

2. Constellation Brands (STZ)

Cannabis investing ideas also lead to this company with a currently neutral to positive market sentiment. Constellation Brands currently has projected quarterly revenue of 83 million and estimated earnings per share of $1.55.

Constellation Brands is a global leader in beer, wine and spirits with a wide variety of popular brands like Corona Extra and Ballast Point.

Constellation Brands made an investment into Canopy Growth Corporation (WEED) for $191 million worth a few years ago due to the potential growth that cannabis holds. Constellation Brands acquired a 40% ownership stake in Canopy Growth and became the third-largest investor in the cannabis industry. The investments were the right decision, and the stock price went up significantly since.

After forming a mid-term low at $104.28 in March 2020, the price per share increased to a new all-time high in April 2022 at $261.52.

See also  Sage CBD Oil

3. AbbVie (ABBV)

AbbVie is a company with a market cap of $200 billion and is a science-led global healthcare company formed in 2013 by the acquisition of Abbott. AbbVie’s product portfolio includes more than 125 products, including pharmaceutical and over-the-counter medications and CBD oil. The stock had a great run from the $60 level in 2000 and market a all-time high in April 2022 at $175.91.

4. Altria (MO)

Altria is a significant producer of tobacco products and has invested in cannabis companies in the past. They have made investments from over $200 million to an equity stake in Cronos Group Inc. a few years back, which is one of the largest Canadian cannabis producers. Not only do they own these stocks, but they also sell cigarettes as well, and the growth potential is enormous. The stock formed a mid-term low at $30.95 in March 2020, and is now trading at $55.23.

5. Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company focused on developing and commercializing novel therapeutics to treat rare, chronic inflammatory diseases that are often difficult to treat with existing therapies. CRBP is still Nasdaq listed but might get OTC listed when it remains trading below $1. Right now, the stock is trading at $0.35.

6. Tilray Inc (TLRY)

Tilray is a Canadian company that produces and sells cannabis products, both medical marijuana. They’re best known for being the first company to legally export cannabis from North America for medical purposes through Europe (Greece). The latest news is that they have entered the world of cannabis recreation. The company is focused on research and development, which has allowed them to offer new products like their High CBD Oil Drops for anxiety relief or insomnia issues. They’re also well-known in Canada because all medical marijuana patients are registered with Tilray’s online system called CanvasRx. Many day traders trade Tilray shares due to its high volatile price action during market hours. The price per share is at $5.3 right now.

7. HEXO Corp. Common Shares (HEXO)

HEXO Corp. is a Canadian cannabis company focused on distributing world-class products within the adult-use and medical markets. HEXO Corp. is one of the leading exporters in Canada’s burgeoning cannabis industry to countries around the world where marijuana is legalized for medicinal or recreational purposes. Like CRBP, the stock is trading below $1 for a while (at $0.41 right now) and might get delisted from Nasdaq.

8. Cronos Group Inc. (CRON)

Cronos Group Inc. is a company focused on medical marijuana and recreational cannabis for adult use. They’re best known for producing, selling, and marketing products in Canada, Germany, Israel, Italy and Australia. Cronos Group announced that they were partnering with Ginkgo Bioworks to engineer yeast that produces cannabinoids genetically. The good thing with Cronos is that they have a lot of room to grow based on solid company fundamentals. Right now, the stock is trading at $3.08.

9. Aurora Cannabis (ACB)

Aurora Cannabis is a Canadian company that is a producer and seller of medical cannabis products. They’re best known for being the first marijuana company to be listed on an American stock exchange. Recently Aurora Cannabis announced that they were entering the European market by acquiring a German company. The stock is currently trading at $3.1. They recently had a formal bid accepted and are set to acquire CanniMed Therapeutics, which has experts speculating that the company could be worth $600 million. Aurora is one of those stocks best to buy because it’s still undervalued due to its marijuana production being in Canada. Still, they have made their intentions known for expansion into Europe unfolding additional potential.

10. ETFMG Alternative Harvest ETF (MJ)

You have already read about the top favorite CBD stocks to buy. Investors can also participate in CBD oil stock growth by buying the exchange-traded fund. The ETFMG Alternative Harvest ETF is a fund that invests in companies operating in the global cannabis industry. The ETFMG Alternative Harvest ETF is an umbrella term as it includes a variety of sectors. The ETF is currently trading at an 5-year low at $8.45.

Introduction to Marijuana Stocks

Marijuana stocks are made up to become a thriving and profitable industry. With the legalization of cannabis in Canada and previously in the United States, stocks are bound to arise.

Cannabis companies are not only for those in North America but all over the world, from Europe to Africa. Cannabis stocks are an opportunity that investors can’t afford to miss out on now! One of the best next best things in speculative investing is CBD oil stocks and similar companies. With marijuana becoming more mainstream, there will be a rise of people looking to invest in this sector.

Marijuana Stocks With the Most Momentum

Momentum investing is when you invest in stocks that have gone up faster than the market. If a stock has risen more than the market, momentum investors think it will continue to do so because of factors that caused it to go up. Investors want to buy stocks with high returns and count on a trend continuation in the subsequent months for the stock. The concept is to analyze data of potential Marijuana stocks to buy via Nasdaq, NYSE or even OTC. While investments in ETFs are often compound profits over the years by contribution to the ETFs, specific investing in Marijuana momentum stocks aim for short-term growth with higher risk and higher potential. Keeping an eye on company financials, earnings, cannabis use, and news is important too.

The Role of the Farm Bill

The farm bill was passed to legalize the production and sale of hemp. This is a major step in the right direction for marijuana stocks and will help make it more mainstream and provide employment opportunities with its legalization. The best thing about investing in cannabis companies is that you can get an ownership stake through stock buybacks or dividends.

How to Gain Access to the Global Cannabis Stock Market

An online broker allows you to invest in marijuana stocks from around the world. It is a great way to diversify your portfolio, find new opportunities, and provide liquidity for international investments. By doing this, you can also invest in companies involved with CBD oil processing and production.

Conclusion About the Best CBD Stocks to Buy

Marijuana stocks are a great way to diversify your portfolio and find new opportunities. Investing in them provides liquidity for international investments and owning an ownership stake through stock buybacks or dividends.

Cbd stocks are a wise investment choice that is forecasted to grow exponentially in the future. The product development recently has resulted in a massive uptick in the interest of CBD stocks, and as such, it is crucial to stay up-to-date with this market.

The best CBD stocks have shown strong revenue growth over the past five years and are positioned for rapid future growth due to their product development. The earnings per share are solid for many companies in the marijuana industry, and more and more brands enter the profitable cannabis market.

It is essential to diversify your portfolio, so it is wise to invest in a range of stocks. Marijuana-focused companies with solid fundamentals, which will allow investors the best returns for their investment at a reasonable stock price, are a good starting point.

About the author: Alexander is the founder of daytradingz.com and has 20 years of experience in the financial markets. He aims to make trading and investing easy to understand for everybody, and has been quoted on Benzinga, Business Insider and GOBankingRates.

How useful was this post?

Click on a star to rate it!

Average rating 3 / 5. Vote count: 1

No votes so far! Be the first to rate this post.